Stocks

The table gives an overview of all stocks, alphabetically sorted.
 24SevenOffice 247 Apr 20, 2021 35.10 +0.29   
 24Storage 24STOR Apr 20, 2021 42.40 -2.53   
 2cureX 2CUREX Apr 20, 2021 18.52 -3.44   
 AAC Clyde Space AAC Apr 20, 2021 2.54 -2.49   
 AAK AAK Apr 20, 2021 197.05 -2.16   
 ABB ABB Apr 20, 2021 274.10 -1.58   
 Abelco Investment Group ABIG Apr 20, 2021 0.12 -3.36   
 Abera Bioscience ABERA Apr 20, 2021 12.70 0.00   
 ABG Sundal Collier Holding ABGO Apr 20, 2021 9.00 0.00   
 Abliva ABLI Apr 20, 2021 0.75 -0.27   
 Absolent Group ABSO Apr 20, 2021 400.00 -1.23   
 Absolicon ABSL Apr 20, 2021 130.00 -5.45   
 AcadeMedia ACAD Apr 20, 2021 91.90 +1.88   
 Acarix ACARIX Apr 20, 2021 1.42 -8.60   
 Acconeer ACCON Apr 20, 2021 40.50 -4.26   
 Acosense ACOS Apr 20, 2021 1.70 -8.36   
 AcouSort ACOU Apr 20, 2021 23.60 -1.46   
 ACQ Bure ACQSPAC 0.00 0.00   
 Acrinova A ACRIA Apr 20, 2021 11.62 0.00   
 Acrinova B ACRIB Apr 20, 2021 13.25 0.00   
 ACROUD ACROUD Apr 20, 2021 3.81 -2.06   
 Actic Group ATIC Apr 20, 2021 17.05 0.00   
 Active Biotech ACTI Apr 20, 2021 1.45 -3.33   
 AcuCort ACUC Apr 20, 2021 4.52 -4.44   
 Adapteo ADAPT Apr 20, 2021 115.00 -1.03   
 AdderaCare ADDERA Apr 20, 2021 7.66 +1.06   
 AddLife B ALIFB Apr 20, 2021 199.30 -6.52   
 Addnode Group B ANODB Apr 20, 2021 279.00 -0.89   
 Addtech B ADDTB Apr 20, 2021 147.00 -2.00   
 ADDvise Group A ADDVA Apr 20, 2021 3.03 -4.42   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK